For laboratory & research use only. Not for human consumption.
Longevity & Cellular Health

How to Read an SS-31 Certificate of Analysis

What KYIN Peptides' SS-31 certificate of analysis actually reports, and how to independently verify it.

What KYIN's SS-31 COA Reports

Every batch of KYIN's SS-31 is independently tested by Janoshik to 99.716% purity. The certificate reports an HPLC purity result and a mass spectrometry identity confirmation verifying the sample's molecular weight matches SS-31's expected amphipathic tetrapeptide sequence.

Why Identity Confirmation Matters for a Clinically Relevant Peptide

SS-31 (elamipretide) is one of the few compounds referenced on this site with a related FDA-approved drug (FORZINITY, for Barth syndrome), which means the exact sequence has real clinical significance rather than being purely a research curiosity. Confirming the sample's identity via mass spectrometry, not just its purity percentage, is the most reliable way to verify you have the correct amphipathic tetrapeptide sequence.

Elamipretide Branding and Search Confusion

Because SS-31's approved-drug name (elamipretide) and brand name (FORZINITY) both circulate online, searches for the compound sometimes surface pages describing the FDA-approved drug's clinical use rather than the research-grade peptide. A certificate of analysis is specific to the research compound KYIN sells, tested for laboratory use, and doesn't carry over any claims associated with the approved pharmaceutical.

How to Verify Independently

Given SS-31's clinical relevance, independently confirming a certificate is particularly worthwhile: search the batch number at janoshik.com/verify to cross-reference it against Janoshik's own records. See our general How to Read a Certificate of Analysis guide for the principles that apply to every compound in KYIN's catalogue.

Back to the full SS-31 research overview →

Research Use Only Notice This page explains how to interpret certificate-of-analysis data for SS-31 and does not constitute medical, dosing, or human-use advice. It is not a claim about current regulatory approval, safety, or legal status in any market. Any SS-31 sourced through KYIN Peptides is sold strictly for laboratory research use by qualified professionals — not for human or animal use, and not intended for diagnostic, therapeutic, or consumption purposes.
FAQ

SS-31 testing questions

What purity does KYIN Peptides' SS-31 meet?

KYIN Peptides' SS-31 is independently tested by Janoshik to 99.716% purity, with mass spectrometry identity confirmation — see the current batch's certificate of analysis on the product page.

Why does identity confirmation matter more for SS-31?

SS-31 (elamipretide) has a related FDA-approved drug (FORZINITY), giving its exact sequence real clinical significance. Mass spectrometry identity confirmation, not purity percentage alone, is the most reliable way to verify the correct sequence is present.

Interested in SS-31?

See pricing, current batch purity, and the full certificate of analysis on the product page.